GW Pharmaceuticals Ltd - Company Profile
Powered by 
All the sales intelligence you need on GW Pharmaceuticals Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how GW Pharmaceuticals Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with GW Pharmaceuticals Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
GW Pharmaceuticals Clinical Trials
Determine GW Pharmaceuticals Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of GW Pharmaceuticals Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| Phase II Clinical Trial of GW117 Tablets in the Treatment of Depression | GDCT0456994 | GW-117 | Central Nervous System | Depression | Phase II | Ongoing, recruiting | GW Pharmaceuticals Ltd |
| A Safety and Efficacy Study of GWP42003-P Oral Solution as Adjunctive Treatment for Japanese Children and Adults with Lennox-gastaut Syndrome, Dravet Syndrome, or Tuberous Sclerosis Complex | GDCT0454622 | cannabidiol | Central Nervous System; Genetic Disorders | Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy); Lennox-Gastaut Syndrome; Seizures; Tuberous Sclerosis | Phase III | Ongoing, recruiting | GW Pharmaceuticals Ltd |
| Adjunctive Cannabidiol Therapy in Patients with CDKL5 Deficiency Disorder. Interventional Drug Study on Efficacy and Safety with Focus on Seizure Effects | GDCT0449283 | cannabidiol | Central Nervous System; Genetic Disorders | Epilepsy; Seizures; Unspecified Genetic Disorders | Phase II | Ongoing, recruiting | Agostino Gemelli University Polyclinic;Catholic University of the Sacred Heart |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer